SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-10-002130
Filing Date
2010-03-12
Accepted
2010-03-12 14:08:48
Documents
7
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2197228z10-k.htm 10-K 1071241
2 EX-23.1.1 a2197228zex-23_11.htm EX-23.1.1 2937
3 EX-23.1.2 a2197228zex-23_12.htm EX-23.1.2 3101
4 EX-31.1.1 a2197228zex-31_11.htm EX-31.1.1 8254
5 EX-31.2.1 a2197228zex-31_21.htm EX-31.2.1 8266
6 EX-32.1.1 a2197228zex-32_11.htm EX-32.1.1 5583
7 G918548.JPG g918548.jpg GRAPHIC 85729
  Complete submission text file 0001047469-10-002130.txt   1219060
Mailing Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046
Business Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 443-545-1819
OSIRIS THERAPEUTICS, INC. (Filer) CIK: 0001360886 (see all company filings)

IRS No.: 710881115 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32966 | Film No.: 10677082
SIC: 2836 Biological Products, (No Diagnostic Substances)